242 related articles for article (PubMed ID: 20962747)
1. Testosterone and 17β-estradiol have opposite effects on podocyte apoptosis that precedes glomerulosclerosis in female estrogen receptor knockout mice.
Doublier S; Lupia E; Catanuto P; Periera-Simon S; Xia X; Korach K; Berho M; Elliot SJ; Karl M
Kidney Int; 2011 Feb; 79(4):404-13. PubMed ID: 20962747
[TBL] [Abstract][Full Text] [Related]
2. Gender-specific effects of endogenous testosterone: female alpha-estrogen receptor-deficient C57Bl/6J mice develop glomerulosclerosis.
Elliot SJ; Berho M; Korach K; Doublier S; Lupia E; Striker GE; Karl M
Kidney Int; 2007 Aug; 72(4):464-72. PubMed ID: 17495854
[TBL] [Abstract][Full Text] [Related]
3. Role of MiR-155 Signal Pathway in Regulating Podocyte Injury Induced by TGF-β1.
Lin X; Zhen X; Huang H; Wu H; You Y; Guo P; Gu X; Yang F
Cell Physiol Biochem; 2017; 42(4):1469-1480. PubMed ID: 28719898
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
Huang H; You Y; Lin X; Tang C; Gu X; Huang M; Qin Y; Tan J; Huang F
Cell Physiol Biochem; 2017; 41(1):163-172. PubMed ID: 28214865
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria.
Li Y; Kang YS; Dai C; Kiss LP; Wen X; Liu Y
Am J Pathol; 2008 Feb; 172(2):299-308. PubMed ID: 18202193
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis in podocytes induced by TGF-beta and Smad7.
Schiffer M; Bitzer M; Roberts IS; Kopp JB; ten Dijke P; Mundel P; Böttinger EP
J Clin Invest; 2001 Sep; 108(6):807-16. PubMed ID: 11560950
[TBL] [Abstract][Full Text] [Related]
7. 17 beta-estradiol and tamoxifen upregulate estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 diabetes.
Catanuto P; Doublier S; Lupia E; Fornoni A; Berho M; Karl M; Striker GE; Xia X; Elliot S
Kidney Int; 2009 Jun; 75(11):1194-1201. PubMed ID: 19279558
[TBL] [Abstract][Full Text] [Related]
8. CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.
Marshall CB; Krofft RD; Pippin JW; Shankland SJ
Am J Physiol Renal Physiol; 2010 May; 298(5):F1140-51. PubMed ID: 20130121
[TBL] [Abstract][Full Text] [Related]
9. Role of Protease-Activated Receptor 2 in Regulating Focal Segmental Glomerulosclerosis.
Wang Y; He Y; Wang M; Lv P; Liu J; Wang J
Cell Physiol Biochem; 2017; 41(3):1147-1155. PubMed ID: 28245472
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor alpha expression in podocytes mediates protection against apoptosis in-vitro and in-vivo.
Kummer S; Jeruschke S; Wegerich LV; Peters A; Lehmann P; Seibt A; Mueller F; Koleganova N; Halbenz E; Schmitt CP; Bettendorf M; Mayatepek E; Gross-Weissmann ML; Oh J
PLoS One; 2011; 6(11):e27457. PubMed ID: 22096576
[TBL] [Abstract][Full Text] [Related]
11. The cyclin-dependent kinase inhibitor p21 is required for TGF-beta1-induced podocyte apoptosis.
Wada T; Pippin JW; Terada Y; Shankland SJ
Kidney Int; 2005 Oct; 68(4):1618-29. PubMed ID: 16164639
[TBL] [Abstract][Full Text] [Related]
12. Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo.
Logar CM; Brinkkoetter PT; Krofft RD; Pippin JW; Shankland SJ
Kidney Int; 2007 Aug; 72(4):489-98. PubMed ID: 17554257
[TBL] [Abstract][Full Text] [Related]
13. Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.
Lee HS; Song CY
Kidney Blood Press Res; 2010; 33(1):24-9. PubMed ID: 20185928
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.
Sakairi T; Abe Y; Kopp JB
Nephrol Dial Transplant; 2011 Sep; 26(9):2746-52. PubMed ID: 21378152
[TBL] [Abstract][Full Text] [Related]
15. Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression.
Chen A; Feng Y; Lai H; Ju W; Li Z; Li Y; Wang A; Hong Q; Zhong F; Wei C; Fu J; Guan T; Liu B; Kretzler M; Lee K; He JC
J Clin Invest; 2020 Oct; 130(10):5523-5535. PubMed ID: 32634130
[TBL] [Abstract][Full Text] [Related]
16. IGF-binding protein-3 modulates TGF-beta/BMP-signaling in glomerular podocytes.
Peters I; Tossidou I; Achenbach J; Woroniecki R; Mengel M; Park JK; Paschy M; de Groot K; Haller H; Schiffer M
J Am Soc Nephrol; 2006 Jun; 17(6):1644-56. PubMed ID: 16672319
[TBL] [Abstract][Full Text] [Related]
17. Raging hormones: gender and renal disease.
Silbiger SR
Kidney Int; 2011 Feb; 79(4):382-4. PubMed ID: 21278778
[TBL] [Abstract][Full Text] [Related]
18. Renin induces apoptosis in podocytes through a receptor-mediated, angiotensin II-independent mechanism.
Yuan H; Ren ZL; Hu FQ; Liang W; Ding GH
Am J Med Sci; 2012 Dec; 344(6):441-6. PubMed ID: 22874619
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic role of TGF-β in the progression of podocyte diseases.
Lee HS
Histol Histopathol; 2011 Jan; 26(1):107-16. PubMed ID: 21117032
[TBL] [Abstract][Full Text] [Related]
20. Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3-Dependent Podocyte-Mesenchymal Transition.
Dan Hu Q; Wang HL; Liu J; He T; Tan RZ; Zhang Q; Su HW; Kantawong F; Lan HY; Wang L
Adv Sci (Weinh); 2023 Nov; 10(32):e2304360. PubMed ID: 37749872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
